Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Second Generation
1.2.3 Third Generation
1.3 Market by Application
1.3.1 Global Cancer Genome Sequencing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Treatment
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genome Sequencing Market Perspective (2018-2033)
2.2 Cancer Genome Sequencing Growth Trends by Region
2.2.1 Global Cancer Genome Sequencing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Genome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Cancer Genome Sequencing Forecasted Market Size by Region (2024-2033)
2.3 Cancer Genome Sequencing Market Dynamics
2.3.1 Cancer Genome Sequencing Industry Trends
2.3.2 Cancer Genome Sequencing Market Drivers
2.3.3 Cancer Genome Sequencing Market Challenges
2.3.4 Cancer Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genome Sequencing Players by Revenue
3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
3.4 Global Cancer Genome Sequencing Market Concentration Ratio
3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2022
3.5 Cancer Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Cancer Genome Sequencing Product Solution and Service
3.7 Date of Enter into Cancer Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genome Sequencing Breakdown Data by Type
4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2024-2033)
5 Cancer Genome Sequencing Breakdown Data by Application
5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Genome Sequencing Market Size (2018-2033)
6.2 North America Cancer Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer Genome Sequencing Market Size by Country (2018-2023)
6.4 North America Cancer Genome Sequencing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Genome Sequencing Market Size (2018-2033)
7.2 Europe Cancer Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer Genome Sequencing Market Size by Country (2018-2023)
7.4 Europe Cancer Genome Sequencing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Sequencing Market Size (2018-2033)
8.2 Asia-Pacific Cancer Genome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Genome Sequencing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Genome Sequencing Market Size (2018-2033)
9.2 Latin America Cancer Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer Genome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Cancer Genome Sequencing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Sequencing Market Size (2018-2033)
10.2 Middle East & Africa Cancer Genome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 GE Healthcare Life Sciences
11.2.1 GE Healthcare Life Sciences Company Detail
11.2.2 GE Healthcare Life Sciences Business Overview
11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2018-2023)
11.2.5 GE Healthcare Life Sciences Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 LI-COR Biosciences
11.4.1 LI-COR Biosciences Company Detail
11.4.2 LI-COR Biosciences Business Overview
11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023)
11.4.5 LI-COR Biosciences Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2018-2023)
11.5.5 Abbott Laboratories Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2018-2023)
11.6.5 Beckman Coulter Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Cancer Genome Sequencing Introduction
11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Hamilton Thorne Biosciences
11.8.1 Hamilton Thorne Biosciences Company Detail
11.8.2 Hamilton Thorne Biosciences Business Overview
11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023)
11.8.5 Hamilton Thorne Biosciences Recent Development
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Detail
11.9.2 Integrated DNA Technologies Business Overview
11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2018-2023)
11.9.5 Integrated DNA Technologies Recent Development
11.10 Microchip Biotechnologies
11.10.1 Microchip Biotechnologies Company Detail
11.10.2 Microchip Biotechnologies Business Overview
11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2018-2023)
11.10.5 Microchip Biotechnologies Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Detail
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
11.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2018-2023)
11.11.5 Myriad Genetics Recent Development
11.12 Commonwealth Biotechnologies
11.12.1 Commonwealth Biotechnologies Company Detail
11.12.2 Commonwealth Biotechnologies Business Overview
11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
11.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2018-2023)
11.12.5 Commonwealth Biotechnologies Recent Development
11.13 ZS Genetics
11.13.1 ZS Genetics Company Detail
11.13.2 ZS Genetics Business Overview
11.13.3 ZS Genetics Cancer Genome Sequencing Introduction
11.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2018-2023)
11.13.5 ZS Genetics Recent Development
11.14 Pacific Biosciences
11.14.1 Pacific Biosciences Company Detail
11.14.2 Pacific Biosciences Business Overview
11.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
11.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023)
11.14.5 Pacific Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Genome Sequencing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Second Generation
Table 3. Key Players of Third Generation
Table 4. Global Cancer Genome Sequencing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Cancer Genome Sequencing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cancer Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Genome Sequencing Market Share by Region (2018-2023)
Table 8. Global Cancer Genome Sequencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cancer Genome Sequencing Market Share by Region (2024-2033)
Table 10. Cancer Genome Sequencing Market Trends
Table 11. Cancer Genome Sequencing Market Drivers
Table 12. Cancer Genome Sequencing Market Challenges
Table 13. Cancer Genome Sequencing Market Restraints
Table 14. Global Cancer Genome Sequencing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Genome Sequencing Market Share by Players (2018-2023)
Table 16. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2022)
Table 17. Ranking of Global Top Cancer Genome Sequencing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cancer Genome Sequencing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Genome Sequencing Product Solution and Service
Table 21. Date of Enter into Cancer Genome Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Genome Sequencing Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Genome Sequencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cancer Genome Sequencing Revenue Market Share by Type (2024-2033)
Table 27. Global Cancer Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Genome Sequencing Revenue Market Share by Application (2018-2023)
Table 29. Global Cancer Genome Sequencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cancer Genome Sequencing Revenue Market Share by Application (2024-2033)
Table 31. North America Cancer Genome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Cancer Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cancer Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Cancer Genome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Cancer Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cancer Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Cancer Genome Sequencing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cancer Genome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Cancer Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cancer Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Cancer Genome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Agilent Technologies Company Detail
Table 47. Agilent Technologies Business Overview
Table 48. Agilent Technologies Cancer Genome Sequencing Product
Table 49. Agilent Technologies Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 50. Agilent Technologies Recent Development
Table 51. GE Healthcare Life Sciences Company Detail
Table 52. GE Healthcare Life Sciences Business Overview
Table 53. GE Healthcare Life Sciences Cancer Genome Sequencing Product
Table 54. GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 55. GE Healthcare Life Sciences Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Cancer Genome Sequencing Product
Table 59. Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. LI-COR Biosciences Company Detail
Table 62. LI-COR Biosciences Business Overview
Table 63. LI-COR Biosciences Cancer Genome Sequencing Product
Table 64. LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 65. LI-COR Biosciences Recent Development
Table 66. Abbott Laboratories Company Detail
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Cancer Genome Sequencing Product
Table 69. Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Beckman Coulter Company Detail
Table 72. Beckman Coulter Business Overview
Table 73. Beckman Coulter Cancer Genome Sequencing Product
Table 74. Beckman Coulter Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 75. Beckman Coulter Recent Development
Table 76. Bayer Company Detail
Table 77. Bayer Business Overview
Table 78. Bayer Cancer Genome Sequencing Product
Table 79. Bayer Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Hamilton Thorne Biosciences Company Detail
Table 82. Hamilton Thorne Biosciences Business Overview
Table 83. Hamilton Thorne Biosciences Cancer Genome Sequencing Product
Table 84. Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 85. Hamilton Thorne Biosciences Recent Development
Table 86. Integrated DNA Technologies Company Detail
Table 87. Integrated DNA Technologies Business Overview
Table 88. Integrated DNA Technologies Cancer Genome Sequencing Product
Table 89. Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 90. Integrated DNA Technologies Recent Development
Table 91. Microchip Biotechnologies Company Detail
Table 92. Microchip Biotechnologies Business Overview
Table 93. Microchip Biotechnologies Cancer Genome Sequencing Product
Table 94. Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 95. Microchip Biotechnologies Recent Development
Table 96. Myriad Genetics Company Detail
Table 97. Myriad Genetics Business Overview
Table 98. Myriad Genetics Cancer Genome Sequencing Product
Table 99. Myriad Genetics Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 100. Myriad Genetics Recent Development
Table 101. Commonwealth Biotechnologies Company Detail
Table 102. Commonwealth Biotechnologies Business Overview
Table 103. Commonwealth Biotechnologies Cancer Genome Sequencing Product
Table 104. Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 105. Commonwealth Biotechnologies Recent Development
Table 106. ZS Genetics Company Detail
Table 107. ZS Genetics Business Overview
Table 108. ZS Genetics Cancer Genome Sequencing Product
Table 109. ZS Genetics Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 110. ZS Genetics Recent Development
Table 111. Pacific Biosciences Company Detail
Table 112. Pacific Biosciences Business Overview
Table 113. Pacific Biosciences Cancer Genome Sequencing Product
Table 114. Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2018-2023) & (US$ Million)
Table 115. Pacific Biosciences Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genome Sequencing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer Genome Sequencing Market Share by Type: 2022 VS 2033
Figure 3. Second Generation Features
Figure 4. Third Generation Features
Figure 5. Global Cancer Genome Sequencing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Cancer Genome Sequencing Market Share by Application: 2022 VS 2033
Figure 7. Treatment Case Studies
Figure 8. Research Case Studies
Figure 9. Cancer Genome Sequencing Report Years Considered
Figure 10. Global Cancer Genome Sequencing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Cancer Genome Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Cancer Genome Sequencing Market Share by Region: 2022 VS 2033
Figure 13. Global Cancer Genome Sequencing Market Share by Players in 2022
Figure 14. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2022
Figure 16. North America Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Cancer Genome Sequencing Market Share by Country (2018-2033)
Figure 18. United States Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Cancer Genome Sequencing Market Share by Country (2018-2033)
Figure 22. Germany Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2018-2033)
Figure 30. China Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Cancer Genome Sequencing Market Share by Country (2018-2033)
Figure 38. Mexico Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Cancer Genome Sequencing Market Share by Country (2018-2033)
Figure 42. Turkey Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Cancer Genome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Agilent Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 45. GE Healthcare Life Sciences Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 46. Johnson & Johnson Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 47. LI-COR Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 48. Abbott Laboratories Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 49. Beckman Coulter Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 50. Bayer Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 51. Hamilton Thorne Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 52. Integrated DNA Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 53. Microchip Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 54. Myriad Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 55. Commonwealth Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 56. ZS Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 57. Pacific Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed